Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents ; volume:13 ; number:1 ; day:28 ; month:6 ; year:2022 ; pages:1-15 ; date:12.2022
Nature Communications ; 13, Heft 1 (28.6.2022), 1-15, 12.2022
- Urheber
-
Rosa Duque, Jaime S.
Wang, Xiwei
Leung, Daniel
Cheng, Samuel M. S.
Cohen, Carolyn A.
Mu, Xiaofeng
Hachim, Asmaa
Zhang, Yanmei
Chan, Sau Man
Chaothai, Sara
Kwan, Kelvin K. H.
Chan, Karl C. K.
Li, John K. C.
Luk, Leo L. H.
Tsang, Leo C. H.
Wong, Wilfred H. S.
Cheang, Cheuk Hei
Hung, Timothy K.
Lam, Jennifer H. Y.
Chua, Gilbert T.
Tso, Winnie W. Y.
Ip, Patrick
Mori, Masashi
Kavian, Niloufar
Leung, Wing Hang
Valkenburg, Sophie
Peiris, Malik
Tu, Wenwei
Lau, Yu Lung
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-022-31485-z
- URN
-
urn:nbn:de:101:1-2022110318530224805659
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rosa Duque, Jaime S.
- Wang, Xiwei
- Leung, Daniel
- Cheng, Samuel M. S.
- Cohen, Carolyn A.
- Mu, Xiaofeng
- Hachim, Asmaa
- Zhang, Yanmei
- Chan, Sau Man
- Chaothai, Sara
- Kwan, Kelvin K. H.
- Chan, Karl C. K.
- Li, John K. C.
- Luk, Leo L. H.
- Tsang, Leo C. H.
- Wong, Wilfred H. S.
- Cheang, Cheuk Hei
- Hung, Timothy K.
- Lam, Jennifer H. Y.
- Chua, Gilbert T.
- Tso, Winnie W. Y.
- Ip, Patrick
- Mori, Masashi
- Kavian, Niloufar
- Leung, Wing Hang
- Valkenburg, Sophie
- Peiris, Malik
- Tu, Wenwei
- Lau, Yu Lung
- SpringerLink (Online service)
Ähnliche Objekte (12)
Author Correction: Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents
Thrombocytopenia and venous thromboembolic events after BNT162b2, CoronaVac, ChAdOx1 vaccines and SARS-CoV-2 infection: a self-controlled case series study
Differential immunogenicity of BNT162b2 or ChAdOx1 vaccines after extended-interval homologous dual vaccination in older people
Immunogenicity evaluation after BNT162b2 booster vaccination in healthcare workers
Baseline gut microbiota and metabolome predict durable immunogenicity to SARS-CoV-2 vaccines
Booster dose of BNT162b2 after two doses of CoronaVac improves neutralization of SARS-CoV-2 Omicron variant
Immunogenicity of intraperitoneal and intranasal liposome adjuvanted VLP vaccines against SARS-CoV-2 infection
Side Effects Related to BNT162b2 and CoronaVac Vaccine Requiring Emergency Department Visit
Immunogenicity of poxvirus-based vaccines against Nipah virus
Effectiveness after immunization with BNT162b2 and Gam-COVID-Vac for SARS-CoV-2 and neutralizing antibody titers in health care workers
Improving the immunogenicity of HIV-1 envelope trimer vaccines
Factors affecting the immunogenicity of influenza vaccines in human
Author Correction: Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents
Thrombocytopenia and venous thromboembolic events after BNT162b2, CoronaVac, ChAdOx1 vaccines and SARS-CoV-2 infection: a self-controlled case series study
Differential immunogenicity of BNT162b2 or ChAdOx1 vaccines after extended-interval homologous dual vaccination in older people
Immunogenicity evaluation after BNT162b2 booster vaccination in healthcare workers
Baseline gut microbiota and metabolome predict durable immunogenicity to SARS-CoV-2 vaccines
Booster dose of BNT162b2 after two doses of CoronaVac improves neutralization of SARS-CoV-2 Omicron variant
Immunogenicity of intraperitoneal and intranasal liposome adjuvanted VLP vaccines against SARS-CoV-2 infection
Side Effects Related to BNT162b2 and CoronaVac Vaccine Requiring Emergency Department Visit
Immunogenicity of poxvirus-based vaccines against Nipah virus
Effectiveness after immunization with BNT162b2 and Gam-COVID-Vac for SARS-CoV-2 and neutralizing antibody titers in health care workers
Improving the immunogenicity of HIV-1 envelope trimer vaccines
Factors affecting the immunogenicity of influenza vaccines in human
Author Correction: Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents
Thrombocytopenia and venous thromboembolic events after BNT162b2, CoronaVac, ChAdOx1 vaccines and SARS-CoV-2 infection: a self-controlled case series study
Differential immunogenicity of BNT162b2 or ChAdOx1 vaccines after extended-interval homologous dual vaccination in older people
Immunogenicity evaluation after BNT162b2 booster vaccination in healthcare workers
Baseline gut microbiota and metabolome predict durable immunogenicity to SARS-CoV-2 vaccines
Booster dose of BNT162b2 after two doses of CoronaVac improves neutralization of SARS-CoV-2 Omicron variant
Immunogenicity of intraperitoneal and intranasal liposome adjuvanted VLP vaccines against SARS-CoV-2 infection
Side Effects Related to BNT162b2 and CoronaVac Vaccine Requiring Emergency Department Visit
Immunogenicity of poxvirus-based vaccines against Nipah virus
Effectiveness after immunization with BNT162b2 and Gam-COVID-Vac for SARS-CoV-2 and neutralizing antibody titers in health care workers
Improving the immunogenicity of HIV-1 envelope trimer vaccines